165 related articles for article (PubMed ID: 6186908)
1. Specificities and binding properties of eight monoclonal antibodies against carcinoembryonic antigen.
Hedin A; Hammarström S; Larsson A
Mol Immunol; 1982 Dec; 19(12):1641-8. PubMed ID: 6186908
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies to carcinoembryonic antigen: a systematic analysis of antibody specificities by using related normal antigens and evidence for allotypic determinants on carcinoembryonic antigen.
Kuroki M; Kuroki M; Koga Y; Matsuoka Y
J Immunol; 1984 Oct; 133(4):2090-7. PubMed ID: 6206151
[TBL] [Abstract][Full Text] [Related]
3. Epitopes of carcinoembryonic antigen (CEA) defined by monoclonal antibodies.
Price MR
Br J Cancer; 1988 Feb; 57(2):165-9. PubMed ID: 2451932
[TBL] [Abstract][Full Text] [Related]
4. Immunochemical identification of an alpha 1-acid glycoprotein-antigenic determinant on carcinoembryonic antigen (CEA) and non-specific cross-reacting antigen (NCA).
Ochi Y; Ura Y; Hamazu M; Fujiyama Y; Kajita Y; Ishida M; Miyazaki T; Tamura K
Clin Chim Acta; 1984 Mar; 138(1):9-19. PubMed ID: 6201306
[TBL] [Abstract][Full Text] [Related]
5. Immunological and biochemical characterization of the nonspecific cross-reacting antigen epitopes using twenty-three monoclonal antibodies.
Kuroki M; Arakawa F; Higuchi H; Haruno M; Wakisaka M; Matsuoka Y
Hybridoma; 1991 Oct; 10(5):557-74. PubMed ID: 1725168
[TBL] [Abstract][Full Text] [Related]
6. Production of monoclonal antibodies against the non-specific cross-reacting antigen (NCA).
Chavanel G; Frenoy N; Escribano MJ; Burtin P
Oncodev Biol Med; 1983; 4(3):209-17. PubMed ID: 6402767
[TBL] [Abstract][Full Text] [Related]
7. Epitope specificity and cross-reactivity pattern of a large series of monoclonal antibodies to carcinoembryonic antigen.
Hedin A; Zoubir F; Lundgren T; Hammarström S
Mol Immunol; 1986 Oct; 23(10):1053-61. PubMed ID: 2432408
[TBL] [Abstract][Full Text] [Related]
8. Determination of the specificities of monoclonal antibodies recognizing members of the CEA family using a panel of transfectants.
Daniel S; Nagel G; Johnson JP; Lobo FM; Hirn M; Jantscheff P; Kuroki M; von Kleist S; Grunert F
Int J Cancer; 1993 Sep; 55(2):303-10. PubMed ID: 7690348
[TBL] [Abstract][Full Text] [Related]
9. Epitopes of carcinoembryonic antigen defined by monoclonal antibodies prepared from mice immunized with purified carcinoembryonic antigen or HCT-8R cells.
Haggarty A; Legler C; Krantz MJ; Fuks A
Cancer Res; 1986 Jan; 46(1):300-9. PubMed ID: 2415248
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies for carcinoembryonic antigen and related antigens as a model system: determination of affinities and specificities of monoclonal antibodies by using biotin-labeled antibodies and avidin as precipitating agent in a solution phase immunoassay.
Wagener C; Clark BR; Rickard KJ; Shively JE
J Immunol; 1983 May; 130(5):2302-7. PubMed ID: 6187848
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity of circulating carcinoembryonic antigen analyzed by sandwich-enzyme immunoassays with different specificities.
Suzuki N; Kondo K; Tominaga S; Kuroki M; Matsuoka Y
Cancer Res; 1987 Sep; 47(18):4782-7. PubMed ID: 2441854
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies for carcinoembryonic antigen and related antigens as a model system: a systematic approach for the determination of epitope specificities of monoclonal antibodies.
Wagener C; Yang YH; Crawford FG; Shively JE
J Immunol; 1983 May; 130(5):2308-15. PubMed ID: 6187849
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibody against carcinoembryonic antigen (CEA) identifies two new forms of crossreacting antigens of molecular weight 90,000 and 160,000 in normal granulocytes.
Audette M; Buchegger F; Schreyer M; Mach JP
Mol Immunol; 1987 Nov; 24(11):1177-86. PubMed ID: 3320743
[TBL] [Abstract][Full Text] [Related]
14. Studies on circulating antibody against carcinoembryonic antigen (CEA) and CEA-like antigen in cancer patients.
Ura Y; Ochi Y; Hamazu M; Ishida M; Nakajima K; Watanabe T
Cancer Lett; 1985 Jan; 25(3):283-95. PubMed ID: 2578868
[TBL] [Abstract][Full Text] [Related]
15. Purification and characterization of a 50,000 mol. wt glycoprotein antigen, and localization of determinants involved in cross-reactivity with carcinoembryonic antigen.
Laferté S; Krantz MJ
Mol Immunol; 1983 Apr; 20(4):421-31. PubMed ID: 6191208
[TBL] [Abstract][Full Text] [Related]
16. Generation, immunologic characterization and antitumor effects of human monoclonal antibodies for carcinoembryonic antigen.
Imakiire T; Kuroki M; Shibaguchi H; Abe H; Yamauchi Y; Ueno A; Hirose Y; Yamada H; Yamashita Y; Shirakusa T; Ishida I; Kuroki M
Int J Cancer; 2004 Feb; 108(4):564-70. PubMed ID: 14696121
[TBL] [Abstract][Full Text] [Related]
17. CEA-specificity of CEA-reactive monoclonal antibodies. Immunochemical and immunocytochemical studies.
Verstijnen CP; Arends JW; Moerkerk PT; Warnaar S; Hilgers J; Bosman FT
Anticancer Res; 1986; 6(1):97-104. PubMed ID: 2420267
[TBL] [Abstract][Full Text] [Related]
18. Epitope mapping of the nonspecific cross-reacting antigen using various related recombinant proteins expressed in Chinese hamster ovary cells and eight distinct monoclonal antibodies.
Kuroki M; Haruno M; Murakami M; Wakisaka M; Oikawa S; Nakazato H; Matsuoka Y
Immunol Invest; 1992 Apr; 21(2):143-58. PubMed ID: 1374735
[TBL] [Abstract][Full Text] [Related]
19. Characterization of carcinoembryonic antigen-specific monoclonal antibodies and specific carcinoembryonic antigen assay in sera of patients.
Kitagawa H; Ohkouchi E; Fukuda A; Imai K; Yachi A
Jpn J Cancer Res; 1986 Sep; 77(9):922-30. PubMed ID: 2429946
[TBL] [Abstract][Full Text] [Related]
20. Natural antibodies against the carcinoembryonic antigen (CEA) and a related antigen, NCA, in human sera.
Frénoy N; Schauffler J; Cahour A; Burtin P
Anticancer Res; 1987; 7(6):1229-33. PubMed ID: 3327450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
